US Critical Path Initiative "gives inadequate attention device sector"
This article was originally published in Clinica
Executive Summary
The FDA's much-vaunted critical path initiative (CPI), which strives to bring the tools used for medical product development into the 21st century, has come under fire both internally and externally for putting too much emphasis on the needs of the pharmaceutical industry at the expense of the device industry. The evidence for this mismatch is both symbolic and substantive, critics say.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.